Investing in Elanco Animal Health Incorporated [ELAN]: What You Must Know


Elanco Animal Health Incorporated’s recently made public that its Director BILBREY JOHN P acquired Company’s shares for reported $99267.0 on Nov 11. In the deal valued at $13.24 per share,7,500 shares were bought. As a result of this transaction, BILBREY JOHN P now holds 41,722 shares worth roughly $ 0.49 million.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Then, Simmons Jeffrey N bought 30,000 shares, generating $436,146 in total proceeds. Upon buying the shares at $14.54, the PRESIDENT, CEO AND DIRECTOR now owns 30,000 shares.

Before that, HOOVER R DAVID bought 20,000 shares. Elanco Animal Health Incorporated shares valued at $303,614 were divested by the Director at a price of $15.18 per share. As a result of the transaction, HOOVER R DAVID now holds 145,000 shares, worth roughly $1.69 million.

Morgan Stanley downgraded its Elanco Animal Health Incorporated [ELAN] rating to an Equal-weight from a an Overweight in a research note published On Friday, August 18, 2022; the price target was decreased to $22 from $37. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in mid August from “an Overweight” to “a Neutral”. Goldman also remained covering ELAN and has decreased its forecast on July 21, 2022 with a “Sell” recommendation from previously “Buy” rating. Piper Sandler started covering the stock on July 12, 2022. It rated ELAN as “a Neutral”.

Price Performance Review of ELAN

On Friday, Elanco Animal Health Incorporated [NYSE:ELAN] saw its stock fall -3.15% to $11.68. Over the last five days, the stock has lost -11.85%. Elanco Animal Health Incorporated shares have fallen nearly -4.42% since the year began. Nevertheless, the stocks have fallen -54.64% over the past one year. While a 52-week high of $29.66 was reached on 02/02/23, a 52-week low of $11.18 was recorded on 02/21/23. SMA at 50 days reached $12.83, while 200 days put it at $15.96. A total of 6.28 million shares were traded, compared to the trading of 4.25 million shares in the previous session.

Levels Of Support And Resistance For ELAN Stock

The 24-hour chart illustrates a support level at 11.55, which if violated will result in even more drops to 11.43. On the upside, there is a resistance level at 11.85. A further resistance level may holdings at 12.02. The Relative Strength Index (RSI) on the 14-day chart is 37.15, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.90, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.29%. Stochastics %K at 17.09% indicates the stock is a buying.

How much short interest is there in Elanco Animal Health Incorporated?

A steep rise in short interest was recorded in Elanco Animal Health Incorporated stocks on Jan 30, 2023, growing by 4.31 million shares to a total of 21.17 million shares. Yahoo Finance data shows the prior-month short interest on Dec 29, 2022 was 16.86 million shares. There was a rise of 20.36%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 4.76% of the overall stock float, the days-to-cover ratio (short ratio) rose to 2.93.

Elanco Animal Health Incorporated [ELAN] – Who Are The Largest Shareholders?

In filings from Dodge & Cox, it is revealed that the company now owns 84,775,075 shares, or roughly 17.88% of the outstanding ELAN shares. In other words, the investor’s shares have risen by 31,773,735 from its previous 13-F filing of 53001340.0. Additionally, The Vanguard Group, Inc. increased 7.08% of its stake after which the total value it holdings stand at $613,730,506, while PRIMECAP Management Co. added 8.42% of its stake to hold $452.86 million in the firm. Over the last quarter, Amundi Asset Management US, Inc. sold -1,909,232 shares of Elanco Animal Health Incorporated, while T. Rowe Price Associates, Inc. sold -8,379,249 shares. At present, Franklin Mutual Advisers LLC is holding 18,570,782 shares valued at $254.98 million. Ontario Teachers’ Pension Plan Bo owned 17,922,193 shares of the company at the time of its most recent 13F filing, worth $246.07 million.

The most recent change occurred on November 18, 2021 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating along with a $40 price target.


Please enter your comment!
Please enter your name here